IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Petroni G, Galassi C, Gouin KH 3rd, Chen HH, Buqué A, Bloy N, Yamazaki T, Sato A, Beltrán-Visiedo M, Campia G, Jiménez-Cortegana C, Shah A, Kirchmair A, Massa C, Wickenhauser C, de Andrea CE, Navarro-Rubio B, Serrano-Mendioroz I, Navarro Manzano E, Satty AM, Rippon B, Finotello F, Trajanoski Z, Zhou XK, Scandura JM, García-Martínez E, Ayala de la Peña F, Rodríguez-Ruiz ME, Seliger B, Sánchez-Margalet V, de la Cruz-Merino L, Basho RK, Shiao SL, McArthur HL, Formenti SC, Knott SRV, Galluzzi L.
Petroni G, et al. Among authors: basho rk.
Nat Cancer. 2025 Jul 7. doi: 10.1038/s43018-025-01007-z. Online ahead of print.
Nat Cancer. 2025.
PMID: 40624238